Helen C. Lockhart, PhD
Shareholder
| Biotechnology
Pardon the interruption, but we are lawyers after all, so we need to make sure you understand that calling, or leaving a message does not establish an attorney-client relationship. Also, you need to know the information in your call will not be considered privileged or confidential unless, of course, we already represent you or have agreed to receive limited confidential material from you as a prospective client.
If you are a client, do not call with time-sensitive patent filing instructions and do not assume we have received or are acting upon your filing instructions unless you receive written confirmation from us.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference.
There, that wasn’t so bad, was it? Thank you for your interest in Wolf Greenfield.
Accept & CallPardon the interruption, but we are lawyers after all, so we need to make sure you understand that sending an email does not establish an attorney-client relationship. Also, you need to know the information in your email will not be considered privileged or confidential unless, of course, we already represent you or have agreed to receive limited confidential material from you as a prospective client.
If you are a client, do not send time-sensitive patent filing instructions just to this email recipient. Also send to filinginstructions@wolfgreenfield.com and do not assume we have received or are acting upon your filing instructions unless you receive written confirmation from us.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference.
There, that wasn’t so bad, was it? Thank you for your interest in Wolf Greenfield.
Accept & EmailEducation
- BS, Biochemistry, University of California at Riverside
- PhD, Biochemistry, Boston University
- JD, Suffolk University Law School, cum laude
Key Technologies
- Immune Response Modulators
- Drug Delivery
- Catalytic Molecules
- Antibodies
- Cell Culture
- Mass Spectrometry
- Nucleic Acid Sequencing
- Drug Delivery Systems
- Peptides
- Small Molecule Mimetics
- Combinatorial Libraries
- Drug Screening Assays
Practice Groups
Admitted to Practice
- Massachusetts
- US Patent and Trademark Office
Location
- Boston
Overview
Helen Lockhart’s practice involves strategic counseling on development and management of domestic and international intellectual property rights for a variety of clients, including universities, smaller and mid-sized companies, start-ups, and entrepreneurs.
Helen has broad experience in prosecuting biotechnology patents relating to immune response modulators, drug delivery, catalytic molecules, antibodies, fluorescence based micro- and nano-analysis, cell culture, mass spectrometry, nucleic acid sequencing, polymer-based and biological-based drug delivery systems, antisense nucleic acid therapeutics, peptides, small molecule mimetics, combinatorial libraries, and drug screening assays. She previously served on the firm’s Executive Committee.
Helen’s doctoral research focused on the regulation of cellular growth and differentiation through signal transduction mechanisms.
Client Testimonial
I have been working with Helen Lockhart on a huge portfolio and she is always good. She has a good relationship with our inventor. She helps me because she can call him directly and get what she needs from him so I don’t have to be on those calls.
Experience
- Developed patent portfolio on a platform technology for a biotechnology company resulting in a substantial out-licensing program with major pharmaceutical companies.
Activities
- American Bar Association
- Boston Bar Association
- Boston Intellectual Property Law Association
- Healthcare Businesswomen's Association
- Massachusetts Bar Association
Recognition
Helen has been repeatedly named to the list of Massachusetts Super Lawyers in the field of intellectual property law. She is also named one of Massachusetts Super Lawyers’ top 100 Women Attorneys. In addition, she has been repeatedly named to The Best Lawyers in America®.
Helen has repeatedly been named a “Life Science Star” by LMG Life Sciences. The LMG Life Sciences guide is based on case evidence and interviews with clients and peers from other law firms.
She has also been repeatedly named to Managing IP’s IP Stars list as a Massachusetts Patent Star and has been repeatedly recognized in the IAM Patent 1000: The World’s Leading Patent Professionals.
Publications
Recent News
See All News
2024
2023
2022
2021
2020
2019
2018